Medicover AB (publ)
MCVEY · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.23 | -0.24 | 0.72 |
| FCF Yield | 1.44% | 2.59% | 0.98% | 1.97% |
| EV / EBITDA | 36.08 | 37.55 | 47.33 | 42.77 |
| Quality | ||||
| ROIC | 1.49% | 1.40% | 0.91% | 0.28% |
| Gross Margin | 23.81% | 22.95% | 21.72% | 21.43% |
| Cash Conversion Ratio | 2.29 | 3.35 | 6.17 | -10.18 |
| Growth | ||||
| Revenue 3-Year CAGR | 11.93% | 11.94% | 11.47% | 10.30% |
| Free Cash Flow Growth | -48.65% | 152.77% | -46.47% | 99.55% |
| Safety | ||||
| Net Debt / EBITDA | 14.03 | 12.54 | 15.51 | 13.94 |
| Interest Coverage | 2.53 | 2.37 | 1.54 | 0.39 |
| Efficiency | ||||
| Inventory Turnover | 7.74 | 7.14 | 6.30 | 6.19 |
| Cash Conversion Cycle | 9.57 | 8.71 | 40.96 | 10.66 |